R-CVP yielded lowest time-to-treatment failure rate in follicular lymphomaHealioResearchers who evaluated three rituximab-containing regimens among patients with follicular lymphoma reported rituximab plus cyclophosphamide, vincristine and prednisone w…
|
Promising results in treating a lymphoma in young people – Science Daily
Science Daily (press release) Wyndham Wilson, M.D., Ph.D., head of NCI’s Lymphoma Therapeutics Section, and colleagues conducted the trial, in which every patient received the drugs etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab in a regimen … |
 Manchester Evening News |
Fresh hope for eye disease sufferers who cannot cry
Manchester Evening News Arthritis Research UK has given a grant of £945,412 for the trial in a bid to find a more effective way to tackle the condition. The researchers are aiming to find out if an existing treatment for rheumatoid arthritis, the drug Rituximab, can also be … |
 Leukaemia & Lymphoma Research |
£1 million for Southampton lymphoma drug research
Leukaemia & Lymphoma Research The introduction of a monoclonal antibody called rituximab over a decade ago heralded their use as an effective treatment for cancer. It doubled the long-term survival rates for many different types of lymphoma when used in combination with chemotherapy. |
Pharmacyclics Earns 4th Milestone – Analyst BlogNASDAQThe third milestone payment of $50 million was triggered on Oct 15, 2012, when Pharmacyclics announced the enrollment of the fifth patient in an international, randomized phase III clinical trial of…
|
NIH researchers’ clinical trials show promising results in treating lymphoma …
pharmabiz.com Wyndham Wilson, head of NCI’s Lymphoma Therapeutics Section, and colleagues conducted the trial, in which every patient received the drugs etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab in a regimen known as … |
 Counsel & Heal |
Adding rituximab helps treat mediastinal B-cell lymphoma
Curetoday.com (press release) NEW YORK (Reuters Health) – A phase II trial in patients with primary mediastinal B-cell lymphoma has found that rituximab can improve the effectiveness of a six-drug anti-cancer cocktail, nearly eliminating the need for radiotherapy. The five-year … NIH trial shows promising results in treating a lymphoma in young peopleNational Institutes of Health (press release) Chemotherapy, no radiation for lymphoma type effectiveUPI.com New Treatment For Lymphoma May Mean Skipping RadiationCounsel & Heal |
Counsel & Heal |
Chemotherapy, no radiation for lymphoma type effective
UPI.com Dr. Wyndham Wilson of the National Cancer Institute, part of the National Institutes of Health, and colleagues conducted the trial, in which every patient received the drugs etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone and rituximab. New Treatment For Lymphoma May Mean Skipping RadiationCounsel & Heal |
Common variable immunodeficiency unmasked by treatment of immune …7thSpace Interactive (press release)To our knowledge this is the first report of development of CVID in a patient with normal immunoglobulin prior to Rituximab treatment.Case presentat…
Combo Tx Gets Perfect Score in LymphomaMedPage TodayWASHINGTON — A three-drug combination — vorinostat (Zolinza), cladribine, and rituximab (Rituxan) — led to a 100% response rate in a small study of patients with advanced mantle cell lymphoma. All …